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Purpose: Urolithiasis develops more frequently in patients with a family history (FHx). 
However, little is known about risk factors in stone formers with a FHx. The aim of this 
study was to examine the clinico-metabolic characteristics of urinary stone formers ac-
cording to FHx.
Materials and Methods: A database of 1,068 stone formers who underwent a complete 
metabolic evaluation was reviewed. The patients were divided into two groups on the 
basis of the presence of a FHx. Clinical factors and metabolic parameters were compared 
between the two groups.
Results: There were no significant differences in clinical characteristics, such as gen-
der, age, body mass index, stone episodes, or multiple stones, between the two groups 
(p＞0.05, respectively). Compared with stone formers without a FHx, however, serum 
calcium concentrations were more elevated in stone formers with a FHx. Also, the uri-
nary excretion of calcium was higher in stone formers with a FHx than in those without 
a FHx. Other urinary metabolites showed no significant differences between the two 
groups (p＞0.05, respectively).
Conclusions: Our study revealed that stone formers with a FHx had increased urinary 
calcium excretion as well as elevated concentrations of serum calcium. This finding sug-
gests that urolithiasis in stone formers with a FHx may be associated with calcium met-
abolic abnormalities.
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INTRODUCTION
Urinary calculi disease is one of the most common uro-
logical disorders, with an incidence of approximately 0.1% 
to 0.3%. The lifetime prevalence is estimated to be about 
5% to 10%, and the risk of stone recurrence in a 10-year peri-
od is approximately 74%. Stone disease typically affects 
adult men 3 times more commonly than adult women and 
shows a peak incidence in the fourth to sixth decades of life 
[1,2]. Currently, the treatment of patients with urolithiasis 
has been greatly changed with advances in minimally in-
vasive techniques, the continued development of which has 
decreased morbidity with better efficacy. However, the re-
currence rate of urinary stone disease is still high despite 
the successful removal of stones. There is no doubt that the 
prevention of stone recurrence is as important as treat-
ment, and preventive measures should be made through 
metabolic evaluation that elucidates the underlying risk 
factors for stone formation.
The risk of stone disease is known to be correlated with 
various environmental factors such as climate, socio-
economic status, geography, dietary habits, and obesity 
[3,4]. Numerous reports have also noted genetic correla-
tions such as sex, age, race, idiopathic hypercalciuria, hy-
peroxaluria, and hyperuricosuria [5-8]. Also, about 25% of 
patients with urolithiasis have a family history of stone dis-
ease, and the relative risk of stone formation is higher in 
men with a family history than in those without a family 
history [7]. In addition, pediatric patients with urolithiasis 
also have a positive family history in 46.2% of first-degree 
and 32.5% of second-degree relatives [9]. Generally, the 
familial affinity of urinary stone disease has been consid-
ered to be affected by environmental factors such as similar 
diet patterns among family members as well as genetic 
influence. However, the limited data make it difficult to 
clarify the potential interaction between family history 
and urolithiasis. Therefore, this study aimed to examine 
the influence of family history on urinary stone disease by Korean J Urol 2010;51:50-53
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TABLE 1. Comparison of clinical characteristics between urinary
stone formers without a family history and those with a family his-
tory
Characteristics
Non-FHx
(n=876)
FHx
(n=192)
p-value
Ages
Sex
   Male (%) 
   Female (%) 
Height (cm)
Weight (kg) 
BMI (kg/m
2)
Episode 
   FSF (%) 
   RSF (%)
Multiplicity 
   Single (%)
   Multiple (%)
44.3±12.3
584 (66.7)
292 (33.3)
164.6±8.5
65.4±11.7
24.0±3.2
589 (67.2)
287 (32.8)
690 (78.8)
186 (21.2)
42.7±13.3
131 (68.2)
  61 (31.8)
164.8±7.7
65.7±11.0
24.1±3.0
117 (60.9)
  75 (39.1)
142 (74.0)
  50 (26.0)
0.105
a
0.677
b
0.796
a
0.744
a
0.782
a
0.095
b
0.146
b
FHx: familial history, BMI: body mass index, FSF: first stone for-
mers, RSF: recurrent stone formers, Data presented as mean±SD
or number of patients, with percentages in parentheses, 
a: 
Student’s t-test, 
b: chi-square test
TABLE 2. Comparison of serum parameters between urinary stone
formers without a family history and those with a family history
Parameters
(unit)
Non-FHx 
(n=876)
FHx
(n=192)
p-value
a
Ca (mg/dl)
P (mg/dl)
UA (mg/dl)
Na (mEq/l)
K (mEq/l)
Cr (mg/dl)
9.2±0.5 
3.4±0.6 
5.4±2.5 
143±3
4.2±0.4 
1.0±0.2 
9.3±0.5 
3.5±0.6 
5.3±1.5 
143±3 
4.2±0.4 
1.0±0.2 
0.048 
0.542
0.647
0.155
0.224
0.220
FHx: familial history, Ca: calcium, P: phosphate, UA: uric acid,
Na: sodium, K: potassium, Cr: creatinine, Data presented as 
mean±SD or number of patients, with percentages in paren-
theses, 
a: Student’s t-test
comparison of clinical features and serum and urinary met-
abolic profiles according to the existence of a family history.
MATERIALS AND METHODS
We reviewed a database of 1,068 patients (715 males and 
353 females) among 4,038 patients who were referred to 
our hospital for urolithiasis between March 1994 and 
February 2008. The patients had completed a metabolic 
evaluation including history taking and serum and 
24-hour urinary examination. Among them, 192 (18%; 131 
males and 61 females) had a family history, whereas 876 
(82%; 584 males and 292 females) did not. Family history 
was defined as positive when any first-degree relative had 
an episode of stone disease; the cases who could not clearly 
remember were excluded. The exclusion criteria were as 
follows: patients with a bladder stone, infection stone, or 
abnormal urinary tract on radiologic exam; patients with 
other metabolic diseases (hyperparathyroidism, hyper-
thyroidism, chronic renal failure, hepatic cirrhosis, etc); 
and inappropriate urine collection.
Within 1 or 2 months after the completion of stone re-
moval, we performed serum chemistry, urinalysis, and cul-
ture measurements and a 24-hour urinary metabolic eval-
uation with the patient on his or her usual diet without any 
medications. Twenty-four-hour urine specimens were col-
lected by discarding the first urine sample right after wak-
ing up and collecting the following urine samples until the 
first urine on the next day in an exclusive bag with 3 cc 
toluene. The patients were instructed to turn in the col-
lected urine within 2 hours. The urinary metabolic evalua-
tion included urine volume, sodium, phosphorus, uric acid, 
calcium, oxalate, citrate, and pH. Given the 24-hour uri-
nary creatinine level, the cases with less than 1.0 g in males 
and 0.8 g in females were excluded in the analysis as having 
an inappropriate collection. Urinary metabolic abnormal-
ities were classified according to the definitions of Lifshitz 
et al [10].
Data analyses were performed by using SPSS Inc. 
(version 12.0, Chicago, USA). Clinical features, serum and 
urinary chemistry indexes, and urinary metabolic abnor-
malities were compared between the two groups. Student’s 
t-test was used for continuous variables, such as serum and 
urinary chemistry indexes, and chi-square test for nominal 
variables, such as the frequency of urinary metabolic 
abnormalities. Statistical significance was set at a p-value 
of less than 0.05.
RESULTS
1. Comparisons of clinical characteristics
No differences were found in sex, age, or body mass index 
(BMI) between the groups (p＞0.05, respectively). Al-
though the group with a family history showed higher rates 
of episode and multiplicity of stones than did the group 
without a family history, these differences were not stat-
istically significant (Table 1).
2. Comparisons of serum metabolites
There were no statistically significant differences in serum 
phosphorus, uric acid, sodium, potassium, or creatinine 
values between the groups with and without a family 
history. However, a statistically significant difference was 
observed in the serum calcium level, with the group with 
a family history showing higher values (9.2±0.5 vs. 9.3±0.5, 
respectively, p=0.048) (Table 2).
3. Comparisons of 24-hour urinary metabolites
Results are shown in Table 3. The urinary excretions of 
phosphorus, uric acid, oxalate, and citrate did not differ sig-
nificantly between the groups. Twenty-four-hour urine 
volume and pH were also similar. However, the urinary ex-
cretion of calcium was significantly higher in the group 
with a family history than in the group without a family 
history (p=0.042).Korean J Urol 2010;51:50-53
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TABLE 4. Comparison of 24-hour urine metabolic abnormalities 
between urinary stone formers without a family history and those
with a family history
Parameters
Non-FHx
(n=876)
FHx
(n=192)
p-value
a
HC (%)
HO (%)
HU (%)
HoC (%)
185/876 (21.1) 
139/876 (15.9) 
198/876 (22.6) 
388/876 (44.3) 
49/192 (25.5) 
31/192 (16.1) 
50/192 (26.0) 
83/192 (43.2) 
0.182
0.924
0.307
0.788
FHx: familial history, HC: hypercalciuria, HO: hyperoxaluria,
HU: hyperuricosuria, HoC: hypocitraturia, 
a: chi-square test
TABLE 3. Comparison of 24-hour urine constituents between uri-
nary stone formers without a family history and those with a fam-
ily history
Parameters
(unit) 
Non-FHx
(n=876)
FHx
(n=192)
p-value
a
Ca (mg/day) 
P (g/day) 
UA (mg/day) 
Oxal (mg/day) 
Cit (mg/day) 
pH 
Vol (ml/day) 
208.8±102.3 
0.79±0.45 
649.8±214.3 
31.2±30.0 
377.3±234.5 
6.1±0.6 
1,798±675
225.6±110.5 
0.68±0.24 
670.8±189.1 
29.3±24.6 
375.6±220.6 
6.1±0.7 
1,835±662
0.042 
0.722 
0.210 
0.415
0.927
0.957
0.492 
FHx: familial history, Ca: calcium, P: phosphate, UA: uric acid,
Oxal: oxalate, Cit: citrate, pH: potential of hydrogen, Vol: volume,
Data presented as mean±SD or numbers of patients, with percen-
tages in parentheses, 
a: Student’s t-test
4. Comparisons of urinary metabolic abnormalities
When urinary metabolic abnormalities were compared be-
tween the groups, the frequency of hypercalciuria, hyper-
oxaluria, hyperuricosuria, and hypocitraturia did not dif-
fer significantly in any of the analyses (Table 4).
DISCUSSION
Although numerous studies have identified the risk factors 
for urolithiasis, the exact cause of stone formation is often 
unknown [5,9]. Hypercalciuria is the most important risk 
factor in calcium stone formation, occurring in 35% to 65% 
of cases. Urinary calcium raises the ionic calcium concen-
tration and increases the urinary saturation of stone-form-
ing calcium salts (calcium-phosphate or calcium-oxalate) 
[11,12]. In addition, complexation of calcium with urinary 
inhibitors such as citrate and glycosaminoglycans reduces 
urinary inhibitory activity, thereby increasing stone risk 
[13,14]. Although hypercalciuria can be accompanied by 
diseases causing a hypercalcemic state such as primary hy-
perparathyroidism, myelo-proliferative disease, vitamin 
D intoxication, or Cushing's syndrome, most hypercal-
ciuria is idiopathic and results from hyper-absorption of 
calcium in the intestine or failure of calcium reabsorption 
in the renal tubule [11]. In addition, hypercalciuria may 
have a genetic predisposition, and about half of patients 
who have hypercalciuria have a family history of stone dis-
ease [15].
Recent studies have suggested a close relation between 
urolithiasis and family history [16,17]. Urolithiasis devel-
ops more frequently in individuals with a family history of 
kidney stones than in those without a family history, but 
little information is available regarding whether the in-
creased risk is attributable to genetic factors, environ-
mental exposures, or some combination. A positive family 
history of stones has been reported in 16% to 37% of pa-
tients who have formed a kidney stone, compared with 4% 
to 22% in healthy control subjects [7,18-20]. Previously, 
Curhan et al examined the association between family his-
tory and risk of kidney stone formation in a cohort of 37,999 
male participants in the Health Professionals Follow-up 
Study [16]. In their study, kidney stone formers with family 
history had significantly higher urinary calcium excretion 
than did those without a family history. They also showed 
that a family history of kidney stones substantially in-
creased the risk of stone formation. Of interest, Lerolle et 
al reported a significant dose-effect association between 
calciuria and stone disease in patients with familial hyper-
calciuria [17]. In the present study, we found that the se-
rum calcium level and urinary calcium excretion were sig-
nificantly higher in the group with a family history than 
in those without a family history. Additionally, our results 
support previous studies showing that a family history of 
urolithiasis is closely associated with an increased risk of 
urinary stone formation [16,17].
Uric acid is an end product of purine metabolism and 
functions as the nucleus of urinary crystallization to induce 
the formation of calcium oxalate stones. It is also respon-
sible for urinary stone formation by reducing the activity 
of inhibitors in the urine [21]. Hyperuricosuria may also be 
related to a family history. This relation can be supported 
by the fact that the metabolism and excretion of uric acid 
may be influenced by inherited factors and that men with 
gouty diathesis are at increased risk of stone formation 
[22,23]. Curhan et al found increased urinary excretion of 
uric acid in a group with a family history of renal stones, 
but statistical significance was not reached [16]. Our re-
sults also revealed no significant difference between ur-
olithiasis patients with and without a family history.
Urinary oxalate excretion has been thought to be im-
portant for urinary stone formation because a small change 
in urinary oxalate can cause a great change in urinary cal-
cium-oxalate saturation. Although there are recognized 
genetic disorders resulting in an overproduction of oxalate, 
such disorders are very rare and the association between 
hyperoxaluria and a family history is still not evident [16].
Hypocitraturia is also known as an important risk fac-
tor for calcium oxalate stone formation [24-26]. However, 
studies on the relation of family history and hypocitraturia 
are scarce, and there has been no research since Curhan 
et al reported a significant increase in citrate excretion in 
patients with a family history [16]. In the present study, Korean J Urol 2010;51:50-53
Metabolic Risk Factors in Familial Urolithiasis 53
we did not find a significant relation between family history 
and hypocitraturia. In light of these results, therefore, it 
is unlikely that urinary citrate excretion is related to family 
history.
Although our data showed no statistical difference in 
the frequency of hypercalciuria (21.1% vs. 25.5%, p=0.182) 
between urolithiasis patients with and without a family 
history, we found that the patients with a family history 
had more elevated serum calcium concentrations and high-
er urinary excretion of calcium than did those without a 
family history. This finding suggests that hypercalciuria 
may be responsible for the familial characteristic of 
urolithiasis.
CONCLUSIONS
In this study, the urolithiasis patients with a family history 
showed higher serum calcium levels than did those without 
a family history and a tendency for increased excretion of 
urinary calcium. This result suggests that a family history 
of urolithiasis might be related to abnormalities in calcium 
metabolism.
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